Update: Neurobiological Technologies Sets Date for Second Quarter Financial Results and Conference Call
February 07 2008 - 7:00AM
PR Newswire (US)
EMERYVILLE, Calif., Feb. 7 /PRNewswire-FirstCall/ --
Neurobiological Technologies, Inc. (NTI(R)) (NASDAQ:NTII), today
announced it will release its second quarter 2008 financial
results, for the quarter ended December 31, 2007, on February 11.
The Company will host a conference call to discuss the earnings and
to give a corporate update. Hosting the call will be Paul E.
Freiman, President and Chief Executive Officer, and Craig W.
Carlson, Vice President and Chief Financial Officer. The details
for the call are as follows: Live Call: -- Date: Monday, February
11, 2008 -- Time: 10:30 a.m. ET, 9:30 a.m. CT, 7:30 a.m. PT --
Dial-in number: 877-857-6147 (U.S.) 719-325-4822 (International)
Webcast of Call: -- A live webcast can be accessed online by going
to: http://investor.shareholder.com/ntii/events.cfm The call will
be archived and accessible at the same website for 90 days
Telephonic Replay: A playback of the conference call will be
available from 10:00 AM PT February 11th through midnight February
15, 2008. Replay number: 888-203-1112 (U.S. and Canada) /
719-457-0820 (international). Replay access code: 3898964. About
Neurobiological Technologies, Inc. NTI is a specialty
biopharmaceutical company with expertise in identifying and
acquiring promising drug candidates and in designing and managing
late-stage clinical trials for central nervous system conditions.
The Company is currently developing Viprinex(TM) (ancrod), a novel
reperfusion agent that is in pivotal Phase 3 trials for the
treatment of acute ischemic stroke. DATASOURCE: Neurobiological
Technologies, Inc. CONTACT: Walter Kass of Cordon Partners, LLC.,
+1-212-300-4708, for Neurobiological Technologies, Inc. Web site:
http://www.ntii.com/
Copyright
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Jul 2024 to Aug 2024
Neurobiological (NASDAQ:NTII)
Historical Stock Chart
From Aug 2023 to Aug 2024